Syros Pharmaceuticals Inc (SYRS) has fallen Thursday morning, with the stock losing -3.31% in pre-market trading to 6.43. SYRS's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 122 out of 146 industries, SYRS ranks higher than 0% of stocks. Syros Pharmaceuticals Inc has fallen 17.49% over the past month, closing at $8.90 on August 25. During this period of time, the stock fell as low as $6.08 and as high as $9.43. SYRS has an average analyst recommendation of Strong Buy. The company has an average price target of $96.00.
SYRS has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on SYRS!